CD200 mRNA expression is reportedly higher in bone, lung, and liver metastatic tissues from patients with aggressive breast cancer than in adjacent noncancerous breast tissues from those with non-metastatic breast cancer [110]. Here, CD200 is linked to breast carcinoma.